Feb 18, 2026 06:44AM

Feb 12, 2026 04:30PM

Feb 3, 2026 06:44AM

Jan 30, 2026 08:31AM

Jan 12, 2026 07:31AM

Jan 6, 2026 06:42AM

Jan 5, 2026 07:35AM Ultragenyx Pharma (RARE) PT Lowered to $52 at Guggenheim

Jan 2, 2026 05:25AM

Dec 31, 2025 09:23AM

Dec 30, 2025 04:06PM

Dec 30, 2025 04:58AM

Dec 30, 2025 04:55AM

Dec 30, 2025 04:54AM

Dec 30, 2025 02:03AM Ultragenyx Pharma (RARE) PT Lowered to $71 at Goldman Sachs

Dec 29, 2025 03:27PM

Dec 29, 2025 03:27PM

Dec 29, 2025 01:50PM

Dec 29, 2025 01:11PM

Dec 29, 2025 12:48PM

Dec 29, 2025 12:12PM

Dec 29, 2025 12:04PM William Blair Reiterates Outperform Rating on Ultragenyx Pharma (RARE)

Dec 29, 2025 12:04PM

Dec 29, 2025 12:03PM

Dec 29, 2025 12:03PM

Dec 29, 2025 08:25AM

Nov 21, 2025 07:13AM

Nov 5, 2025 09:34AM

Nov 5, 2025 04:51AM Ultragenyx Pharma (RARE) PT Lowered to $72 at RBC Capital

Nov 4, 2025 04:19PM

Oct 17, 2025 05:56AM

Sep 22, 2025 07:15AM

Sep 9, 2025 06:49AM

Aug 18, 2025 08:06AM

Jul 28, 2025 06:58AM

Jul 14, 2025 08:01AM Health Canada approves Evkeeza for infants as young as 6 months with HoFH

Jul 14, 2025 05:08AM

Jul 11, 2025 05:05PM

Jul 11, 2025 04:30PM

Jul 10, 2025 10:52AM

Jul 10, 2025 07:49AM

Jul 10, 2025 07:43AM

Jul 10, 2025 06:44AM Canaccord Genuity Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Jul 10, 2025 06:42AM

Jul 10, 2025 06:20AM

Jul 10, 2025 06:01AM

Jul 10, 2025 05:50AM

Jul 9, 2025 04:51PM

Jul 9, 2025 04:05PM

Jun 27, 2025 08:00AM Ultragenyx Pharma (RARE) Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome

Jun 23, 2025 10:33AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All